22 Patents
- US125706202026Covalent Inhibitors of Creatine Kinase (CK) and Uses Thereof for Treating and Preventing Cancer
Dana-farber Cancer Institute, Inc.
0 cites - 0 cites
- 0 cites
- US125094552025Imidazopyridine Derivatives and Aza-imidazopyridine Derivatives as Janus Kinase 2 Inhibitors and Uses Thereof
Dana-farber Cancer Institute, Inc.
0 cites - US124912512025Degraders of Cyclin-dependent Kinase 7 (CDK7) and Uses Thereof
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites - 0 cites
- US124158162025Benzothiazole Derivatives and 7-aza-benzothiazole Derivatives as Janus Kinase 2 Inhibitors and Uses Thereof
Dana-farber Cancer Institute, Inc.
0 cites - US123656642025Small Molecule Inhibitors of SRC Tyrosine Kinase
Board Of Regents Of The University Of Texas System
0 cites - 0 cites
- US122811262025Inhibitors of Cyclin-dependent Kinase 7 and Uses Thereof
Dana-farber Cancer Institute, Inc.
0 cites - 0 cites
- US122274882025Small Molecule Degraders of Helios and Methods of Use
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- US119326252024Inhibitors of Cyclin-dependent Kinase 12 (CDK12) and Uses Thereof
Dana-farber Cancer Institute, Inc.
0 cites - US118588972024Substituted 6,11-dihydro-5h-benzo[b]carbazoles as Inhibitors of ALK and SRPK
Dana-farber Cancer Institute, Inc.
0 cites - US118276362023Degradation of Cyclin-dependent Kinase 8 (CDK8) by Conjugation of CDK8 Inhibitors with E3 Ligase Ligand and Methods of Use
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites - 0 cites
- 0 cites